NCT01714518 Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases Status COMPLETED Phase N/A
NCT01713413 Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases Status COMPLETED Phase NA
NCT01600352 Specific Autoantibody Testing in Patients With Interstitial Lung Disease Status COMPLETED Phase N/A
NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Status COMPLETED Phase PHASE3
NCT01559129 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease Status TERMINATED Phase PHASE2
NCT01462006 Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase NA
NCT01381666 Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701) Status TERMINATED Phase PHASE2
NCT01203943 A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) Status TERMINATED Phase PHASE2
NCT01064609 "Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. Status COMPLETED Phase NA
NCT01055730 The Impact of Pulmonary Rehabilitation in Interstitial Lung Disease Status COMPLETED Phase N/A
NCT00883129 Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II) Status COMPLETED Phase PHASE2
NCT00820729 Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease Status COMPLETED Phase N/A
NCT00744614 Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients Status TERMINATED Phase N/A
NCT00705133 Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE2